Citadel Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-250,719
Closed -$54.4M 15161
2021
Q1
$54.4M Buy
250,719
+220,913
+741% +$41.5M 0.06% 991
2020
Q4
$3.44M Sell
29,806
-72,591
-71% -$8.13M ﹤0.01% 4350
2020
Q3
$9.97M Sell
102,397
-741,353
-88% -$85.3M 0.01% 2303
2020
Q2
$104M Sell
843,750
-133,236
-14% -$15.1M 0.14% 388
2020
Q1
$85.6M Buy
976,986
+699,524
+252% +$74.1M 0.13% 399
2019
Q4
$29M Sell
277,462
-723,444
-72% -$81.1M 0.04% 1154
2019
Q3
$115M Buy
1,000,906
+554,472
+124% +$84.2M 0.14% 346
2019
Q2
$77M Sell
446,434
-90,819
-17% -$15.7M 0.09% 507
2019
Q1
$90.6M Buy
537,253
+46,496
+9% +$6.92M 0.12% 403
2018
Q4
$47.8M Sell
490,757
-434,644
-47% -$57M 0.07% 649
2018
Q3
$160M Buy
925,401
+494,640
+115% +$71.3M 0.19% 247
2018
Q2
$60.1M Sell
430,761
-424,449
-50% -$60.3M 0.08% 600
2018
Q1
$96.4M Buy
855,210
+141,100
+20% +$17.7M 0.15% 336
2017
Q4
$94.3M Buy
714,110
+549,911
+335% +$64.6M 0.13% 353
2017
Q3
$16.7M Buy
164,199
+119,904
+271% +$12.8M 0.03% 1204
2017
Q2
$4.44M Sell
44,295
-836
-2% -$90K 0.01% 2245
2017
Q1
$5.46M Sell
45,131
-36,443
-45% -$4.47M 0.01% 1949
2016
Q4
$9.12M Buy
81,574
+78,710
+2,748% +$9.47M 0.02% 1440
2016
Q3
$380K Sell
2,864
-62,862
-96% -$6.01M ﹤0.01% 5285
2016
Q2
$6.02M Buy
65,726
+40,504
+161% +$3.41M 0.01% 1666
2016
Q1
$1.82M Sell
25,222
-26,041
-51% -$1.43M ﹤0.01% 2747
2015
Q4
$3.56M Buy
51,263
+22,894
+81% +$1.86M 0.01% 2144
2015
Q3
$2.59M Buy
28,369
+21,270
+300% +$2.37M ﹤0.01% 2626
2015
Q2
$872K Buy
7,099
+1,791
+34% +$203K ﹤0.01% 4153
2015
Q1
$484K Sell
5,308
-7,345
-58% -$596K ﹤0.01% 4955
2014
Q4
$856K Sell
12,653
-13,361
-51% -$976K ﹤0.01% 3952
2014
Q3
$2.1M Sell
26,014
-59,676
-70% -$5.28M ﹤0.01% 2800
2014
Q2
$9.19M Buy
85,690
+32,503
+61% +$2.26M 0.02% 1327
2014
Q1
$3.16M Buy
+53,187
New +$3.16M 0.01% 2187

Other funds holding GWPH